Ignite Creation Date:
2024-05-06 @ 5:50 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05446467
Status:
RECRUITING
Last Update Posted:
2024-03-26
First Post:
2022-06-30
Brief Title:
Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC
Sponsor:
Zhejiang Provincial Peoples Hospital
Organization:
Zhejiang Provincial Peoples Hospital
Organization Data
Organization:
Zhejiang Provincial Peoples Hospital
Class:
OTHER
Study ID:
KPF20220630
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Zhejiang Provincial Peoples Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Minghua Ge
Responsible Party Title:
Director
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Zhejiang Provincial Peoples Hospital
Old Name:
None
Old Organization:
None